Bihua Chen
Angel · California
Board director at 10 startups that filed Form D raises since late 2024, mostly in California.
- Stages
- Series A to Growth
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Jul 2024
Focus
HealthcareBiotech & PharmaRecent portfolio activity
- Jul 2024
Adona Medical
Board seat · CA
- Jan 2024
BlossomHill Therapeutics
Board seat · CA
- Dec 2023
Graviton BioScience
Board seat · NY
- Dec 2023
Supira Medical
Board seat · CA
- Oct 2023
Interius BioTherapeutics
Board seat · PA
- Oct 2023
Akura Medical
Board seat · CA
- Apr 2023
Tiger Biotherapeutics
Board seat · NJ
- Mar 2023
Chroma Medicine
Board seat · MA
- Feb 2023
BiVACOR
Board seat · CA
- Feb 2023
Tioga Cardiovascular
Board seat · CA
Sources
- SEC Form D: Tioga CardiovascularFeb 14, 2023
- SEC Form D: BiVACORFeb 21, 2023
- SEC Form D: Chroma MedicineMar 1, 2023
- SEC Form D: Tiger BiotherapeuticsApr 5, 2023
- SEC Form D: Akura MedicalOct 6, 2023
- SEC Form D: Interius BioTherapeuticsOct 20, 2023
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.